NCT06426979View on ClinicalTrials.gov

Sequential Letrozole and Methotrexate Therapy Role in Treatment of Tubal Ectopic Pregnancy

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 1, 2023

Study Completion Date

January 1, 2024

Conditions
Pregnancy Tubal
Interventions
DRUG

Methotrexate

Methotrexate 25 mg/ml was given as single-dose of intramuscular (IM) injection in a dose of 50 mg/m2.

DRUG

Letrozole

FEMARA 2.5 mg tablets two tablets daily

Trial Locations (1)

44519

Zagazig university, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV